1,312
Participants
Start Date
May 12, 2014
Primary Completion Date
April 17, 2023
Study Completion Date
December 31, 2035
Model 400 aortic valve bioprosthesis
Inselspital - Universitätsspital Bern, Bern
UniversitätsSpital Zürich, Zurich
The Mount Sinai Medical Center, New York
New York-Presbyterian Hospital/Columbia University Medical Center, New York
Maimonides Medical Center, Brooklyn
Ospedale San Raffaele - Milano, Milan
University of Maryland Medical Center, Baltimore
Piedmont Hospital, Atlanta
Medizinische Hochschule Hannover, Hanover
University of Florida Shands, Gainesville
Hôpital Cardiologique du Haut-Lévêque, Bordeaux
Riverside Methodist Hospital (OhioHealth), Columbus
ProMedica Toledo Hospital, Toledo
Uniklinik Köln, Cologne
Universitäts Klinikum Frankfurt - Goethe-Universität, Frankfurt
Oklahoma Heart Hospital, Oklahoma City
Hôpital Bichat - Claude Bernard, Paris
Houston Methodist Hospital, Houston
University of Southern California (USC) University Hospital, Los Angeles
University of Colorado Hospital, Aurora
Hartford Hospital, Hartford
Massachusetts General Hospital, Boston
University of Michigan Cardiovascular Center, Ann Arbor
Minneapolis Heart Institute Foundation, Minneapolis
Cleveland Clinic, Cleveland
Cardiothoracic and Vascular Surgeons (CTVS), Austin
University of Washington Medical Center, Seattle
Aurora Saint Luke's Medical Center, Milwaukee
London Health Sciences Centre - University Campus, London
University of Ottawa Heart Institute, Ottawa
Montreal Heart Institute, Montreal
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec
Toronto General Hospital, Toronto
Deutsches Herzzentrum München, Munich
Herzzentrum Leipzig GmbH, Leipzig
Leids Universitair Medisch Centrum (LUMC), Leiden
Erasmus MC, Rotterdam
Guy's & St Thomas' NHS Foundation Trust - St Thomas' Hospital, London
Collaborators (1)
Medtronic
INDUSTRY
Medtronic Cardiac Surgery
INDUSTRY